BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28288046)

  • 21. Primary Left Tibial Epithelioid Hemangioendotheliomas With Multiple Metastases Revealed by FDG PET/CT Imaging.
    Zhao H; Han J; Qin L; Zhang C
    Clin Nucl Med; 2016 Nov; 41(11):872-873. PubMed ID: 27607156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
    Roop MJ; Singh B; Singh H; Watts A; Kohli PS; Mittal BR; Singh G
    Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
    Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
    Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
    Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
    Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
    J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Chague P; Phan CM; Lapusan S; Zhang-Yin J; Cottereau AS
    Diagn Interv Imaging; 2019 Sep; 100(9):527-528. PubMed ID: 30853415
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
    Zhang W; Zhuang H; Servaes S
    Clin Nucl Med; 2016 Aug; 41(8):632-3. PubMed ID: 26825196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower-Extremity Pseudomyogenic Hemangioendothelioma on Bone Scintigraphy and PET/CT.
    Krebs S; Monti S; Lewis N; Luciano A; Rastrelli L; Mannelli L
    Clin Nucl Med; 2017 May; 42(5):383-385. PubMed ID: 28288045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M; Soler M; Riera E; García JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report 18F-FDG PET/CT of Pseudomyogenic Hemangioendothelioma.
    Plouznikoff N; Mourad SA; Turpin S; Turcotte RE; Mitchell DA; Lambert R
    Clin Nucl Med; 2020 May; 45(5):368-369. PubMed ID: 32108703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
    Demirkaya O; AlQahtani M; Alsugair A; Aras O; Abouzied ME
    Nucl Med Commun; 2017 Sep; 38(9):780-787. PubMed ID: 28704338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.
    Zhang B; He Q; Shi X; Wang X; Zhang X
    Clin Nucl Med; 2017 Oct; 42(10):e449-e451. PubMed ID: 28806258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
    Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
    Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
    Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
    Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging.
    Dong Q; Wong KK; Avram AM
    Clin Nucl Med; 2008 Jan; 33(1):30-1. PubMed ID: 18097253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.
    Huyge V; Garcia C; Vanderstappen A; Alexiou J; Gil T; Flamen P
    Clin Nucl Med; 2009 Jul; 34(7):417-20. PubMed ID: 19542943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma.
    Kim J; Chen W; Resnik C; Dilsizian V; Chen Q; Kimball AS
    Clin Nucl Med; 2015 Apr; 40(4):325-7. PubMed ID: 25290293
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Garcia JR; Riera E; Bassa P; Mourelo S; Soler M
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):325-328. PubMed ID: 28262495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.